Skip to content
lifestyle.hungrybear.net
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Vector Sciences & Therapeutics
Vector Science & Therapeutics Announces Landmark Exclusive cGMP Manufacturing Agreement with LyoGenesis Plus for Its Proprietary Peptide Portfolio
July 7, 2026
Vector Science & Therapeutics Files Provisional Patent for Breakthrough Transdermal Peptide Delivery Platform
June 30, 2026
Gary Payton II Named Chief Athletic Ambassador of Valor
June 22, 2026
Vector Science & Therapeutics Names Dexter Fowler as Chief Athletic Officer for Its Valor Platform
June 12, 2026
Vector Science & Therapeutics Agrees to an Option to Invest in LyoGenesis Plus, Securing Long-Term Access to FDA-Registered, cGMP Manufacturing
May 13, 2026
Vector Science & Therapeutics Enters Three-Year Development and Manufacturing Agreement with MPP Group LLC
May 11, 2026
Vector Science & Therapeutics Expands Board of Directors with Appointment of Dr. Alexander Dobranowski and Scott Kelly
May 6, 2026
Vector Science & Therapeutics Files Provisional Patent for Novel Microneedle Catheter Platform for Intratumoral Drug Delivery
May 1, 2026
Vector Science & Therapeutics Announces Tommy Thompson as Chairman of the Board
April 30, 2026